Answers are grounded in this paper and cite their sources.
The purpose of this study was to develop and validate a bioanalytical method to analyze total levothyroxine and total liothyronine in human serum using chemiluminescence micro particle immunoassay (CMIA) and its application to bioequivalence study. Bioanalysis of human biomarkers such as levothyroxine (T4) and liothyronine (T3) serve the purpose to identify and control the disease progression, if detected timely in the patient. Analysis of these endogenous compounds requires very high technical expertise in terms of sample preparation and its result interpretation. Unless necessary, regulatory guidance discourages to work with surrogate matrix for calibration curve (CC) standard preparation.
No takes yet. Share an insight, caveat, or question.
A 2023 study studied this question.
Synapse has enriched 9 related papers. Consider them for comparative context: